Literature DB >> 21807777

Preferential association of interferon regulatory factor 5 gene variants with seronegative rheumatoid arthritis in 2 Swedish case-control studies.

Chuan Wang1, Heidi Kokkonen, Johanna K Sandling, Martin Johansson, Maria Seddighzadeh, Leonid Padyukov, Solbritt Rantapää-Dahlqvist, Ann-Christine Syvänen.   

Abstract

OBJECTIVE: Two interferon regulatory factor 5 (IRF5) gene variants were examined for association with rheumatoid arthritis (RA).
METHODS: A total of 2300 patients with RA and 1836 controls were recruited from 2 independent RA studies in Sweden. One insertion-deletion polymorphism (CGGGG indel) and one single-nucleotide polymorphism (rs10488631) in the IRF5 gene were genotyped and analyzed within RA subgroups stratified by rheumatoid factor (RF) and anticitrullinated peptide antibodies (ACPA).
RESULTS: The CGGGG indel was preferentially associated with the RF-negative (OR 1.29, p = 7.9 × 10(-5)) and ACPA-negative (OR 1.27, p = 7.3 × 10(-5)) RA subgroups compared to the seropositive counterparts. rs10488631 was exclusively associated within the seronegative RA subgroups (RF-negative: OR 1.24, p = 0.016; ACPA-negative: OR 1.27, p = 4.1 × 10(-3)).
CONCLUSION: Both the CGGGG indel and rs10488631 are relevant for RA susceptibility, especially for seronegative RA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807777     DOI: 10.3899/jrheum.110322

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population.

Authors:  Chikashi Terao; Koichiro Ohmura; Yuta Kochi; Katsunori Ikari; Yukinori Okada; Masakazu Shimizu; Naoshi Nishina; Akari Suzuki; Keiko Myouzen; Takahisa Kawaguchi; Meiko Takahashi; Kiyoshi Takasugi; Akira Murasawa; Shinichi Mizuki; Mitsuhiro Iwahashi; Keiko Funahashi; Masamitsu Natsumeda; Moritoshi Furu; Motomu Hashimoto; Hiromu Ito; Takao Fujii; Kazuhiko Ezawa; Tsukasa Matsubara; Tsutomu Takeuchi; Michiaki Kubo; Ryo Yamada; Atsuo Taniguchi; Hisashi Yamanaka; Shigeki Momohara; Kazuhiko Yamamoto; Tsuneyo Mimori; Fumihiko Matsuda
Journal:  Arthritis Res Ther       Date:  2015-04-18       Impact factor: 5.156

2.  Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients.

Authors:  José A Gómez-Puerta; Raquel Celis; M Victoria Hernández; Virginia Ruiz-Esquide; Julio Ramírez; Isabel Haro; Juan D Cañete; Raimon Sanmartí
Journal:  Arthritis Res Ther       Date:  2013-11-07       Impact factor: 5.156

3.  Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.

Authors:  Marit Stockfelt; Anna-Carin Lundell; Merete Lund Hetland; Mikkel Østergaard; Till Uhlig; Marte Schrumpf Heiberg; Espen A Haavardsholm; Michael T Nurmohamed; Jon Lampa; Dan Nordström; Kim Hørslev Petersen; Bjorn Gudbjornsson; Gerdur Gröndal; Jonathan Aldridge; Kerstin Andersson; Kaj Blennow; Henrik Zetterberg; Ronald van Vollenhoven; Anna Rudin
Journal:  Arthritis Res Ther       Date:  2021-07-13       Impact factor: 5.156

4.  A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study.

Authors:  Lucia Vernerova; Frantisek Spoutil; Miroslav Vlcek; Katarina Krskova; Adela Penesova; Milada Meskova; Andrea Marko; Katarina Raslova; Branislav Vohnout; Jozef Rovensky; Zdenko Killinger; Ivana Jochmanova; Ivica Lazurova; Guenter Steiner; Josef Smolen; Richard Imrich
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

5.  Rare variants in non-coding regulatory regions of the genome that affect gene expression in systemic lupus erythematosus.

Authors:  Sarah A Jones; Stuart Cantsilieris; Huapeng Fan; Qiang Cheng; Brendan E Russ; Elena J Tucker; James Harris; Ina Rudloff; Marcel Nold; Melissa Northcott; Wendy Dankers; Andrew E J Toh; Stefan J White; Eric F Morand
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.